This study investigated Nectin-4 and TROP-2 expression in 87 UTUC patients, including 54 with a history of concurrent UBC (UTUC + UBC) and 33 with UTUC alone. Here, TACSTD2 is linked to renal pelvis/ureter urothelial carcinoma.